What is Geron Corporation (GERN) stock price today?

Geron Corporation (GERN) currently trades at $1.54 per share. The stock has a market capitalization of $980.58M and a P/E ratio of —x.

Is GERN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Geron Corporation has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Geron Corporation's revenue and earnings?

Geron Corporation has trailing twelve-month (TTM) revenue of $183.88M with profit margins of -45.40%. Earnings per share (EPS) is $-0.13.

GERN

Geron Corporation

NASDAQ: GERN · HEALTHCARE · BIOTECHNOLOGY

$1.54

+1.99% today

Updated 2026-04-30

Market cap

$980.58M

P/E ratio

—

P/S ratio

5.33x

EPS (TTM)

$-0.13

Dividend yield

—

52W range

$1 – $2

Volume

19.1M

Market cap

$980.58M

P/E ratio

—

P/S ratio

5.33x

EPS (TTM)

$-0.13

Dividend yield

—

52W range

$1 – $2

Volume

19.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$3.40

+120.78%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy3 Buy1 Hold1 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at -45.40%

- Negative free cash flow $-22.10M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$596000.00	$237000.00	$76.99M	$183.88M	$183.88M
Net income	$-141.90M	$-184.13M	$-174.57M	$-85.78M	$-31.14M
EPS	—	—	—	—	$-0.13
Free cash flow	$-127.81M	$-168.57M	$-219.30M	$-111.09M	$-22.10M
Profit margin	-23,808.89%	-77,690.72%	-226.73%	-46.65%	-45.40%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-13	WILLIAMS, TIMOTHY	Buy	2,500,000	—
2026-03-31	SPIEGEL, ROBERT J.	Buy	5,243	$1.49
2026-03-25	CHINOPOROS, CONSTANTINE	Buy	270,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GERN	$980.58M	25	4.3	2.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Geron Corporation trades at $1.54. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $183.88M. with profit margins at -45.40%.

Frequently asked questions

What is Geron Corporation's stock price?

Geron Corporation (GERN) trades at $1.54.

Is Geron Corporation overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Geron Corporation (GERN)?

The analyst target price is $3.40, representing +120.8% upside from the current price of $1.54.

What is Geron Corporation's revenue?

TTM revenue is $183.88M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio5.33x

ROE-33.00%

Beta0.67

50D MA$1.63

200D MA$1.39

Shares out0.64B

Float0.51B

Short ratio—

Avg volume19.1M

Performance

1 week+0.67%

1 month+1.34%

3 months+10.22%

YTD+14.39%

1 year—

3 years—

5 years—

Compare

GERN vs LLY →GERN vs JNJ →GERN vs ABBV →Stock screener →